Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-29 10:33 am Sale | 2026-06-26 | 13G | ORAMED PHARMACEUTICALS INC. NE ORMP | BML Investment Partners, L.P. | 1,026,269 2.500% | -2,261,262 (-68.78%) | Filing History |
| 2026-05-18 10:02 am Purchase | 2026-05-15 | 13G | OUTSET MED INC OM | BML Investment Partners, L.P. | 2,519,701 13.600% | 323,000 (+14.70%) | Filing History |
| 2026-05-14 10:30 am Purchase | 2026-05-12 | 13G | ENGENE HLDGS INC ENGN | BML Investment Partners, L.P. | 6,669,908 9.950% | 1,444,908 (+27.65%) | Filing History |
| 2026-05-13 9:23 pm Purchase | 2026-05-08 | 13G | ENGENE HLDGS INC ENGN | BML Investment Partners, L.P. | 5,225,000 7.800% | 5,225,000 (New Position) | Filing History |
| 2026-05-12 4:44 pm Sale | 2026-05-11 | 13G | KEZAR LIFE SCIENCES INC KZR | BML Investment Partners, L.P. | 0 0.000% | -720,787 (Position Closed) | Filing History |
| 2026-05-12 4:41 pm Purchase | 2026-05-11 | 13G | OUTSET MED INC OM | BML Investment Partners, L.P. | 2,196,701 11.800% | 294,500 (+15.48%) | Filing History |
| 2026-04-27 7:26 pm Sale | 2026-04-23 | 13G | ACLARIS THERAPEUTICS INC ACRS | BML Investment Partners, L.P. | 13,950,000 9.900% | -300,000 (-2.11%) | Filing History |
| 2026-03-19 09:43 am Purchase | 2026-03-12 | 13G | TILLYS INC TLYS | BML Investment Partners, L.P. | 2,189,186 9.400% | 2,189,186 (New Position) | Filing History |
| 2026-02-13 5:52 pm Purchase | 2026-02-12 | 13G | OUTSET MED INC OM | BML Investment Partners, L.P. | 1,902,201 10.500% | 196,325 (+11.51%) | Filing History |
| 2026-02-09 2:39 pm Purchase | 2025-12-31 | 13G | KEZAR LIFE SCIENCES INC KZR | BML Investment Partners, L.P. | 720,787 9.800% | 352,193 (+95.55%) | Filing History |
| 2026-02-09 2:29 pm Purchase | 2025-12-31 | 13G | INSTIL BIO INC TIL | BML Investment Partners, L.P. | 645,600 9.500% | 205,600 (+46.73%) | Filing History |
| 2026-02-09 2:19 pm Purchase | 2025-12-31 | 13G | PMV PHARMACEUTICALS INC PMVP | BML Investment Partners, L.P. | 5,292,000 9.900% | 1,825,316 (+52.65%) | Filing History |
| 2026-02-09 2:13 pm Purchase | 2025-12-31 | 13G | ORAMED PHARMACEUTICALS INC. NE ORMP | BML Investment Partners, L.P. | 3,287,531 8.300% | 643,624 (+24.34%) | Filing History |
| 2026-02-09 2:02 pm Purchase | 2025-12-31 | 13G | ATEA PHARMACEUTICALS INC AVIR | BML Investment Partners, L.P. | 7,810,000 9.900% | 593,688 (+8.23%) | Filing History |
| 2026-02-09 1:42 pm Unchanged | 2025-12-31 | 13G | ACLARIS THERAPEUTICS INC ACRS | BML Investment Partners, L.P. | 14,250,000 11.900% | 0 (Unchanged) | Filing History |
| 2026-01-14 4:23 pm Purchase | 2026-01-12 | 13G | OUTSET MED INC OM | BML Investment Partners, L.P. | 1,705,876 9.400% | 1,705,876 (New Position) | Filing History |
| 2025-12-18 3:47 pm Sale | 2025-12-18 | 13G | ATHIRA PHARMA INC ATHA | BML Investment Partners, L.P. | 0 0.000% | -302,716 (Position Closed) | Filing History |
| 2025-12-09 6:05 pm Sale | 2025-12-09 | 13D | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners, L.P. | 0 0.000% | -2,149,880 (Position Closed) | Filing History |
| 2025-12-05 6:18 pm Sale | 2025-12-04 | 13D | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners, L.P. | 2,149,880 9.700% | -1,099,446 (-33.84%) | Filing History |
| 2025-11-10 12:32 pm Unchanged | 2025-11-10 | 13D | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners, L.P. | 3,249,326 15.600% | 0 (Unchanged) | Filing History |